This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
Jefferies Reaffirms Their Sell Rating on Roche Holding AG (RHHVF)
In a report released today, Michael Leuchten from Jefferies maintained a Sell rating on Roche Holding AG, with a price target of CHF230.00.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
According to TipRanks, Leuchten is ranked #11351 out of 12161 analysts.
Currently, the analyst consensus on Roche Holding AG is a Moderate Buy with an average price target of CHF349.90.
The company has a one-year high of CHF374.90 and a one-year low of CHF243.90. Currently, Roche Holding AG has an average volume of 1.14M.
Read More on RHHVF:
Disclaimer & DisclosureReport an Issue
- Roche reports Q1 group sales CHF 14.7B vs. CHF 15.4B last year
- Roche expects increase in group sales in mid single digit range for FY26
- Genentech’s treatment of KRAS G12C-positive NSCLC granted FDA orphan designation
- Genetech says Phase III METEROID study of Enspryng meets primary endpoint
- Roche announces U.S. FDA accepted sBLA for Gazyva/Gazyvaro
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
